Accept Refuse

EUR-Lex Access to European Union law

This document is an excerpt from the EUR-Lex website

Document 62017CN0013

Case C-3/17: Request for a preliminary ruling from the Conseil d’État (France) lodged on 12 January 2017 — Fédération des entreprises de la beauté v Ministre des Affaires sociales et de la Santé, Ministre de l’éducation nationale, de l’enseignement supérieur et de la recherche, Ministre de l’économie et des finances

OJ C 95, 27.3.2017, p. 6–6 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

27.3.2017   

EN

Official Journal of the European Union

C 95/6


Request for a preliminary ruling from the Conseil d’État (France) lodged on 12 January 2017 — Fédération des entreprises de la beauté v Ministre des Affaires sociales et de la Santé, Ministre de l’éducation nationale, de l’enseignement supérieur et de la recherche, Ministre de l’économie et des finances

(Case C-3/17)

(2017/C 095/12)

Language of the case: French

Referring court

Conseil d’État

Parties to the main proceedings

Applicant: Fédération des entreprises de la beauté

Defendants: Ministre des Affaires sociales et de la Santé, Ministre de l’éducation nationale, de l’enseignement supérieur et de la recherché, Ministre de l’économie et des finances

Questions referred

1.

Does the recognition of equivalent courses that Member States may give in accordance with Article 10(2) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (1) concern only the courses delivered in countries outside the European Union?

2.

Do the provisions of Article 10(2) of the Regulation authorise a Member State to determine the disciplines that may be regarded as ‘similar’ to medicine, pharmacy or toxicology, within the meaning of the Regulation, and the levels of qualification that satisfy the requirements of the Regulation?

3.

If the answer to the second question is in the affirmative, according to what criteria may the disciplines be considered ‘similar’ to medicine, pharmacy or toxicology?


(1)  OJ 2009 L 342, p. 59.


Top